Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... of treatment with vascular endothelial growth factor receptor 3 (VEGFR-3) neutralizing antibody, VEGFR-2 neutralizing antibody, or isotype IgG. Animals were subjected to near-infrared ... and Lymphatic Drainage via Vascular Endothelial Growth Factor Receptor 3 Blockade Increases the Severity of Inflammation in a Mouse Model of Chronic Inflammatory ...
2009 NOV 23 ... green fluorescent protein to quantify the rate of ER-to-Golgi protein trafficking. I14 antibody, which detects only correctly folded VSVG, was employed to probe the folding environment ... folding and promoted strong ER stress but only slightly reduced protein trafficking. Blockade of ER-to-Golgi protein trafficking with brefeldin A (BFA) was sufficient to trigger ER ...
2009 NOV 16 ... reported results from (1) a phase 1 study of FG-3019, the company's human monoclonal antibody against CTGF, in patients with diabetes and advanced albuminuria, (2) a study of the ... albuminuria, (2) a study of the effects of sodium intervention and angiotensin receptor blockade (ARB) on urinary CTGF levels in patients with non-diabetic proteinuria, and (3) a study ...
2009 NOV 2 ... cutoff of 300 ng/mL. The 21 vaccinated subjects (38%) who attained serum IgG anticocaine antibody levels of 43 mu g/mL or higher (ie, high IgG level) had significantly more cocaine-free ... subjects attained these IgG levels and they had only 2 months of adequate cocaine blockade," wrote B.A. Martell and colleagues. The researchers concluded: "Thus, we ...
2009 NOV 23 ... granule cell dispersion, in the dentate gyrus of the hippocampal formation. Moreover, antibody blockade of Reelin in normal, adult mice resulted in granule cell dispersion. Collectively these ...
2009 NOV 2 ... an IL-10(F129S) transgene in the second injection. Blockade of IL-10, by a neutralizing antibody, either between the two injections or after the second injection induces therapeutic ...
2009 NOV 16 ... with MART-1(26-35) peptide and administered with a dose escalation of the CTLA4-blocking antibody tremelimumab. Sixteen patients were accrued to five dose levels. Primary end points were ... their study in Clinical Cancer Research (Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma. Clinical Cancer Research, 2009;15(19):6267-6276). ...
2009 NOV 2 ... in hepatic metastasis was shown by comparison of high versus low-expressing populations, antibody blockade, and ectopic expression," scientists writing in the journal Cancer Research report. ...
2009 NOV 9 ... whole blood thrombelastography and whether a modified routine assay (using factor ME antibody) can be used to detect factor XIII deficiency. Normal whole blood was incubated with ... evaluated the effect of factor XIII inhibition and additional glycoprotein (GP) IIb/IIIa blockade on (platelet-inhibited) whole blood thrombelastography and whether a modified routine ...
2009 NOV 2 ... "To exploit this pathway pharmacologically, we generated a fully human monoclonal antibody, 1-7F9, which cross-reacts with KIR2DL1, -2, and -3 receptors, and prevents their ... The researchers concluded: "These data show that 1-7F9 confers specific, stable blockade of KIR, boosting NK-mediated killing of HLA-matched AML blasts in vitro and in vivo, ...
2009 NOV 16 ... cells and neural progenitors. Blockade of Gal-3 activity by infusing a neutralizing antibody against Gal-3 into the ischemic striatum decreased ischemia-induced angiogenesis and the ...
2009 NOV 2 ... T cell receptor-alpha beta (TCR alpha beta)(+) and CD4(-)8(-)TCR gamma alpha(+) T cells. Antibody-mediated blockade of interleukin-17 (IL-17) as well as the receptor for IL-23, a key ...
2009 NOV 2 ... "To investigate the efficacy of a murine anti-interleukin-6 receptor (anti-IL-6R) antibody in directly blocking tumor necrosis factor (TNF)- and RANKL-mediated osteoclastogenesis ... antibody, and osteoclast formation and bone erosion were assessed in arthritic paws. Blockade of IL-6R dose dependently reduced osteoclast differentiation and bone resorption in ...
2009 NOV 16 ... development." "We examined the antitumor activity of CP-751,871, a human antibody that blocks IGF-1R ligand binding, alone and in combination with rapamycin against ... Hospital. The researchers concluded: "These data suggest a model in which blockade of IGF-1R suppresses tumor-derived VEGF to a level where rapamycin can effectively ...
2009 NOV 2 ... the HA synthesis inhibitor 4-methylumbelliferone (MU) or an antiCD44-neutralizing antibody. The response of CNV was analyzed by volumetric measurements 1 week after ... together with macrophage infiltration into the lesions. Consistently, antibody-based blockade of CD44 resulted in a significant reduction of CNV volume, compared with the isotype ...
2009 NOV 2 ... writing in the journal Cell Stem Cell report. "We found that each antibody inhibited tumor growth and that the combination of the two antibodies was more effective ... Hoey and colleagues published their study in Cell Stem Cell (DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency. Cell Stem Cell, ...
2009 NOV 9 ... mucosa. We used these mice to demonstrate that blockade of IL-15 signaling with an antibody (TM-beta 1) that binds to murine IL-2/IL-15Rbeta (CD122) leads to a reversal of the ...
2009 NOV 16 ... in Long Evans rats with streptozotocin, and an anti-alpha 4 integrin/CD49d neutralizing antibody was injected 5 and 10 days later. Two weeks after streptozotocin administration, ... vivo. Retinal VEGF and TNF-alpha levels and NF-kappa B activity were measured by ELISA. Blockade of alpha 4 integrin/CD49d attenuated the diabetes- induced upregulation of NF-kappa B ...
2009 OCT 19 ... whereas ICAM-1, E-selectin, and VCAM-1 were not altered during HUVEC conditioning. Antibody blockade against CD44v4, CD44v5, and CD44v7 inhibited PMN but not PBL binding. The observed ...
2009 NOV 2 ... and confocal microscopy, respectively. Effect of CCR2 deletion or blockade by antibody and antagonist was determined. Expression of mRNA for MCP-1 increased as EAU developed ...
